-
Wisconsin Pharmacal and Coleman introduce personalized first aid tins
JACKSON, Wis. — Wisconsin Pharmacal, in an exclusive licensing partnership with the Coleman Co., has introduced unique, individualized first aid tins. Each tin contains commonly used first aid components including bandages, antibiotic ointment, antiseptic wipes and more, and comes packaged in a nostalgic, brushed-metal tin case with an embossed first aid cross adorning the lid.
-
FDA approves GlaxoSmithKline's raxibacumab for anthrax
LONDON — The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.
GSK announced the approval of raxibacumab for adults and children who have inhaled Bacillus anthracis. The drug is designed for combination with antibiotics and for preventing inhalational anthrax when alternative therapies aren't available. The drug is the result of a project that Human Genome Sciences, now owned by GSK, began working on in 2001 in response to terrorist anthrax attacks in the United States.